Liver diseases in developing countries.

Liver diseases are an important and largely neglected health issue in low and middle income countries, which carry the highest burden. In this Topic Highlight, experts review hepatitis B and E, alcoholic liver disease, hepatic diseases in human immunodeficiency virus -infected individuals, hepatocellular carcinoma. Numerous gaps in our knowledge that need to be filled are outlined and feasible solutions to the several problems related to diagnosis and management of liver diseases in developing countries are suggested.

• Publication year

  2012

• Venue

  World Journal of Hepatology

• Publication date

  2012-03-27

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.4254/wjh.v4.i3.66PMID 22489257PMCID PMC3321491
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis A: Epidemiology and prevention in developing countries.

  2012cited by this paper
• Human immunodeficiency virus infection and the liver.

  2012cited by this paper
• Hepatocellular carcinoma in developing countries: Prevention, diagnosis and treatment.

  2012cited by this paper
• Hepatitis B: Epidemiology and prevention in developing countries.

  2012cited by this paper
• Alcoholic liver disease.

  2012cited by this paper
• Hepatitis E: Epidemiology and prevention.

  2011cited by this paper
• Management of hepatitis B in developing countries.

  2011cited by this paper
• [Epidemiology and prevention of hepatitis A and B in developing countries].

  2011cited by this paper

• Multi-site, multi-vendor development and validation of a deep learning model for liver stiffness prediction using abdominal biparametric MRI

  2025cites this paper
• Magnitude, patterns, and factors associated with liver disease among clinically suspected clients in Eastern Ethiopia: hidden public health tragedy

  2025cites this paper
• Traditional uses, phytochemistry, pharmacology, and nutraceutical potential of horse gram (Macrotyloma uniflorum): A systematic review.

  2024cites this paper
• Harnessing Immunoinformatics for Precision Vaccines: Designing Epitope-Based Subunit Vaccines against Hepatitis E Virus

  2024cites this paper
• Liver Diseases: perspective from the Philippines.

  2023cites this paper
• A novel, low-cost paper-based liver function point-of-care system

  2023cites this paper
• Extracorporeal blood purification in patients with liver failure: Considerations for the low-and-middle income countries of Latin America

  2023cites this paper
• An MMP‐degraded and cross‐linked fragment of type III collagen as a non‐invasive biomarker of hepatic fibrosis resolution

  2022cites this paper
• Sociodemographic and medical characteristics of liver cirrhosis deaths in a Ghanaian tertiary hospital

  2022influential citation
• Hepatitis A: Leading Cause of Paediatric Acute Liver Failure in Bangladesh

  2022cites this paper
• Global, regional, and national burden and quality of care index of liver cirrhosis by cause from global burden of disease 1990–2019

  2022cites this paper
• Liposomal Form of 2,4-Dinitrophenol Lipophilic Derivatives as a Promising Therapeutic Agent for ATP Synthesis Inhibition

  2022cites this paper
• Hepatoprotective Effects of Crude Stem Bark Extracts and Solvent Fractions of Cordia africana against Acetaminophen-Induced Liver Injury in Rats

  2022cites this paper
• Protective Effect of Chemically Characterized Polyphenol-Rich Fraction from Apteranthes europaea (Guss.) Murb. subsp. maroccana (Hook.f.) Plowes on Carbon Tetrachloride-Induced Liver Injury in Mice

  2021cites this paper
• Hepatoprotective Plants from Bangladesh: A Biophytochemical Review and Future Prospect

  2021cites this paper
• Hepatoprotective effect of essential phospholipids enriched with virgin coconut oil (Phoscoliv) on paracetamol-induced liver toxicity.

  2021cites this paper
• Hepatitis B Awareness and Vaccination Patterns among Healthcare Workers in Africa.

  2020cites this paper
• Noninvasive Biomarkers for Liver Fibrosis

  2020cites this paper
• Hepatoprotective and antioxidant properties of the methanol leaf extract of Diaphananthe bidens in acetaminophen-induced hepatotoxicity in rats

  2019cites this paper
• Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network

  2019cites this paper
• A quantitative electrochemical assay for liver injury.

  2019cites this paper
• Fabrication of antimicrobial curcumin stabilized platinum nanoparticles and their anti-liver fibrosis activity for potential use in nursing care.

  2019cites this paper
• Towards better diagnostic tools for liver injury in low-income and middle-income countries

  2019cites this paper
• Antifibrotic Activity and In Ovo Toxicity Study of Liver-Targeted Curcumin-Gold Nanoparticle.

  2018cites this paper
• Comparison of All Oral With SubCutaneous Drugs Response in Chronic Hepatitis C Patients Using Non-Invasive Markers

  2018cites this paper
• Etiology of Chronic Liver Disease in Ethiopia: A Case Control Study with Special Reference to Viral Hepatitis and Alcohol.

  2018cites this paper
• Non-invasive tests and markers for liver fibrosis

  2017cites this paper
• Incidence and Molecular Characterization of Hepatitis E Virus from Swine in Eastern Cape, South Africa

  2017cites this paper
• Burden of Chronic Viral Hepatitis and Liver Cirrhosis in Brazil - the Brazilian Global Burden of Disease Study.

  2017cites this paper
• Knowledge of Hepatitis B Transmission Risks Among Health Workers in Tanzania.

  2016cites this paper
• Liver involvement in human immunodeficiency virus infection

  2016cites this paper
• Epidemiological, clinical, virological features of hepatitis B newly diagnosed in 2011 in Marseille University hospitals, southeastern France

  2016cites this paper
• Association of a novel TAS2R38 haplotype with alcohol intake among Mexican-Mestizo population.

  2015cites this paper
• Some biochemical and haematological changes in rats pretreated with aqueous stem bark extract of Lophira lanceolata and intoxicated with paracetamol (acetaminophen)

  2014cites this paper
• Noninvasive Biomarkers of Liver Fibrosis: An Overview

  2014cites this paper
• Anti-hepatitis C virus activity of crude extract and fractions of Entada africana in genotype 1b replicon systems.

  2014cites this paper
• Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.

  2013cites this paper